Thymic myeloid cells are heterogenous and include a novel population of transitional dendritic cells
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F25%3A10505726" target="_blank" >RIV/00216208:11310/25:10505726 - isvavai.cz</a>
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=VyfMR76O9Y" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=VyfMR76O9Y</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1084/jem.20250733" target="_blank" >10.1084/jem.20250733</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Thymic myeloid cells are heterogenous and include a novel population of transitional dendritic cells
Popis výsledku v původním jazyce
Myeloid cells, including dendritic cells (DCs) and macrophages, are essential for establishing central tolerance in the thymus by promoting T cell clonal deletion and regulatory T cell (Treg) generation. Previous studies suggest that the thymic DC pool consists of plasmacytoid DC (pDC), XCR1(+) DC1, and SIRPα(+) DC2. Yet the precise origin, development, and homeostasis, particularly of DC2, remain unresolved. Using single-cell transcriptomics and lineage-defining mouse models, we identify nine major populations of thymic myeloid cells and describe their lineage identities. What was previously considered to be "DC2" is actually composed of four distinct cell lineages. Among these are monocyte-derived DCs (moDCs) and monocyte-derived macrophages (moMacs), which are dependent on thymic IFN to upregulate MHCII and CD11c. We further demonstrate that conventional DC2 undergo intrathymic maturation through CD40 signaling. Finally, amongst DC2, we identify a novel thymic population of CX3CR1(+) transitional DC (tDC), which represents transendothelial DCs positioned near thymic microvessels. Together, these findings reveal the thymus as a niche for diverse, developmentally distinct myeloid cells and elucidate their specific requirements for development and maturation.
Název v anglickém jazyce
Thymic myeloid cells are heterogenous and include a novel population of transitional dendritic cells
Popis výsledku anglicky
Myeloid cells, including dendritic cells (DCs) and macrophages, are essential for establishing central tolerance in the thymus by promoting T cell clonal deletion and regulatory T cell (Treg) generation. Previous studies suggest that the thymic DC pool consists of plasmacytoid DC (pDC), XCR1(+) DC1, and SIRPα(+) DC2. Yet the precise origin, development, and homeostasis, particularly of DC2, remain unresolved. Using single-cell transcriptomics and lineage-defining mouse models, we identify nine major populations of thymic myeloid cells and describe their lineage identities. What was previously considered to be "DC2" is actually composed of four distinct cell lineages. Among these are monocyte-derived DCs (moDCs) and monocyte-derived macrophages (moMacs), which are dependent on thymic IFN to upregulate MHCII and CD11c. We further demonstrate that conventional DC2 undergo intrathymic maturation through CD40 signaling. Finally, amongst DC2, we identify a novel thymic population of CX3CR1(+) transitional DC (tDC), which represents transendothelial DCs positioned near thymic microvessels. Together, these findings reveal the thymus as a niche for diverse, developmentally distinct myeloid cells and elucidate their specific requirements for development and maturation.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30102 - Immunology
Návaznosti výsledku
Projekt
<a href="/cs/project/GM25-16606M" target="_blank" >GM25-16606M: Zánětlivé tranzitní dendritické buňky jako klíčoví hráči v toleranci T buněk</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Experimental Medicine
ISSN
0022-1007
e-ISSN
1540-9538
Svazek periodika
223
Číslo periodika v rámci svazku
1
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
21
Strana od-do
e20250733
Kód UT WoS článku
001597579000001
EID výsledku v databázi Scopus
2-s2.0-105019736286